Risk Evaluation for Coronary Artery Disease in Patients With Impaired Glucose Tolerance After a Successful Coronary Intervention

被引:0
|
作者
Horigome, Mitsuaki [1 ]
Hattori, Naoya [2 ]
Kasai, Hiroki [1 ]
Horigome, Miki [1 ]
Sakurai, Shumpei [3 ]
Oguchi, Kazuhiro [4 ]
Ikeda, Uichi [1 ]
机构
[1] Shinshu Univ, Dept Cardiovasc Med, Grad Sch Med, Matsumoto, Nagano 390, Japan
[2] Aizawa Hosp, Adv Res Inst, Matsumoto, Nagano, Japan
[3] Aizawa Hosp, Dept Cardiovasc Med, Matsumoto, Nagano, Japan
[4] Aizawa Hosp, Dept Radiol, Matsumoto, Nagano, Japan
关键词
positron emission tomography (PET); coronary artery disease; impaired glucose tolerance (IGT); coronary risk factor; endothelial function; MYOCARDIAL BLOOD-FLOW; ENDOTHELIAL DYSFUNCTION; INSULIN-RESISTANCE; PET; ANGIOGRAPHY; VASOMOTION; RESPONSES; SMOKING;
D O I
10.1097/RLU.0b013e318217aeac
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: Patients with coronary artery disease (CAD) often have risk factors that may influence endothelial function. The purpose of this study was to evaluate the endothelial function and its association with coronary risk factors after percutaneous coronary intervention (PCI). Materials and Methods: A total of 14 patients with impaired glucose tolerance and CAD underwent positron emission tomography with N-13 ammonia to measure myocardial blood flow (MBF) at rest and during a cold pressor test (CPT), to estimate endothelial function as a percent increase (%increase) of MBF. The results were compared among normal segments (normal), reperfused segments with PCI (PCI), and nonculprit CAD segments without PCI (non-PCI). Correlations between the %increase and major risk factors were also investigated. Results: CPT induced significant increase in MBF in all groups. The %increase of normal, non-PCI, and PCI groups were 33% +/- 22%, 21% +/- 23%, and 26% +/- 23%, respectively. Comparison with risk factors demonstrated significant correlations only in the non-PCI group. Specifically, there were negative correlations between %increase and fasting blood sugar (r = -0.64, P < 0.05), hemoglobin A1c (r = -0.74, P < 0.05), total cholesterol (r = -0.87, P < 0.05), triglyceride (r = -0.71, P < 0.05), and low-density lipoprotein cholesterol (r = -0.92, P < 0.005), respectively. Conclusions: Although impaired glucose tolerance patients with a PCI-treated coronary stenosis showed preserved response to CPT, the %increase negatively correlated with risk factors in the non-PCI segments. Therefore, coronary risk factors may affect CAD lesions in PCI-treated patients.
引用
收藏
页码:546 / 552
页数:7
相关论文
共 50 条
  • [21] Factors contributing to exercise tolerance in patients with coronary artery disease undergoing percutaneous coronary intervention
    Li, Husheng
    Wei, Minqian
    Zhang, Lili
    Huang, Lan
    Wang, Yiyan
    Wang, Jiaqi
    Zhuang, Shaowei
    Wu, Xubo
    Wu, Jing
    BMC SPORTS SCIENCE MEDICINE AND REHABILITATION, 2023, 15 (01)
  • [22] The evolution of depressive symptoms in coronary artery disease patients after successful coronary angioplasty
    Dudek, Dominika
    Siwek, Marcin
    Datka, Wojciech
    Wrobel, Andrzej
    Zieba, Abdrzej
    PSYCHIATRIA POLSKA, 2007, 41 (02) : 217 - 227
  • [23] Knowledge and prevalence of risk factors for coronary artery disease in patients after the first and repeated percutaneous coronary intervention
    Wojcicki, Krzysztof
    Krycinska, Roza
    Tokarek, Tomasz
    Siudak, Zbigniew
    Dziewierz, Artur
    Rajtar-Salwa, Renata
    Januszek, Rafal
    Siwiec, Andzelika
    Reczek, Lukasz
    Dudek, Dariusz
    KARDIOLOGIA POLSKA, 2020, 78 (02) : 147 - 153
  • [24] Thrombin generation test for evaluation of antiplatelet treatment in patients with coronary artery disease after percutaneous coronary intervention
    Berezovskaya, Gelena
    Smirnova, Olga
    Malev, Eduard
    Khromov-Borisov, Nikita
    Klokova, Elena
    Karpenko, Mikhail
    Papayan, Lyudmila
    Petrishchev, Nikolay
    PLATELETS, 2018, 29 (02) : 185 - 191
  • [25] Pioglitazone improves insulin sensitivity and endothelial function in coronary artery disease patients with unknown impaired glucose tolerance
    Rizza, S.
    Cardellini, M.
    Savo, A.
    Clementi, F.
    Porzio, O.
    Romeo, F.
    Lauro, R.
    Federici, M.
    DIABETOLOGIA, 2006, 49 : 145 - 146
  • [26] CRP, fibrinogen, and white blood cell count in patients with stable coronary artery disease and impaired glucose tolerance
    Langer, P
    Saely, CH
    Aczel, S
    Marte, T
    Moll, W
    Drexel, H
    DIABETOLOGIA, 2004, 47 : A414 - A415
  • [27] Is cytisine contraindicated in smoking patients with coronary artery disease after percutaneous coronary intervention?
    Ramotowski, Bogumil
    Budaj, Andrzej
    KARDIOLOGIA POLSKA, 2021, 79 (7-8) : 813 - 819
  • [28] Obesity paradox in asian patients with coronary artery disease after percutaneous coronary intervention
    Kaneko, H.
    Yajima, J.
    Oikawa, Y.
    Tanaka, S.
    Fukamachi, D.
    Suzuki, S.
    Matsuno, S.
    Kano, H.
    Aizawa, T.
    Yamashita, T.
    EUROPEAN HEART JOURNAL, 2013, 34 : 804 - 805
  • [29] The impact of vildagliptin on the daily glucose profile and coronary plaque stability in impaired glucose tolerance patients with coronary artery disease: VOGUE—A multicenter randomized controlled trial
    Hiroyuki Yamamoto
    Akihide Konishi
    Toshiro Shinke
    Hiromasa Otake
    Masaru Kuroda
    Tsuyoshi Osue
    Takahiro Sawada
    Tomofumi Takaya
    Hiroya Kawai
    Naoko Hashimoto
    Takeshi Ohara
    Yushi Hirota
    Kazuhiko Sakaguchi
    Takashi Omori
    Wataru Ogawa
    Ken-ichi Hirata
    BMC Cardiovascular Disorders, 21
  • [30] Lipoprotein(a) and cardiovascular outcomes in patients with coronary artery disease and impaired glucose metabolism
    Sa, D.
    Dos Reis, R. Palma
    Santos, M.
    Temtem, M.
    Sousa, A. C.
    Henriques, E.
    Rodrigues, M.
    Freitas, S.
    Borges, S.
    Ornelas, I.
    Drumond, A.
    Mendonca, M. I.
    EUROPEAN HEART JOURNAL, 2022, 43 : 1153 - 1153